G A Tannock
Overview
Explore the profile of G A Tannock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cunningham S, Lew A, Tannock G
Avian Pathol
. 2009 Feb;
30(6):613-9.
PMID: 19184955
Chicken anaemia virus protein VP3 (Apoptin) was cloned and expressed as a recombinant protein and evaluated for its suitability as a serodiagnostic reagent. VP3 was expressed as a fusion protein...
2.
De Laney D, Morrow C, Read K, Tannock G
Avian Pathol
. 2008 May;
27(5):472-7.
PMID: 18484031
Standardized challenge viruses are essential for the evaluation of Marek's disease (MD) vaccines with many MD challenge preparations consisting of lymphocytes or whole blood from infected birds. Virus present in...
3.
Marsh G, Tannock G
Expert Opin Biol Ther
. 2005 Apr;
5(3):369-80.
PMID: 15833074
Despite their significance, the only available vaccines against respiratory viruses are those for the prevention of influenza. Attempts have been made to produce vaccines against other respiratory viruses using traditional...
4.
Audsley J, Tannock G
J Virol Methods
. 2004 Dec;
123(2):187-93.
PMID: 15620401
The growth of the Russian live attenuated influenza vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57 and B/USSR/60/69 was studied in cells of the VERO and Madin-Darby canine kidney (MDCK) lines as six-well...
5.
Audsley J, Tannock G
Expert Opin Biol Ther
. 2004 May;
4(5):709-17.
PMID: 15155162
Pandemic influenza A viruses of avian origin are of particular concern and have crossed the species barrier several times in recent years, giving rise to illness and occasionally death in...
6.
Tannock G, Tan J, Mawhinney K, Todd D, ORourke D, Bagust T
Aust Vet J
. 2004 Apr;
81(7):428-30.
PMID: 15084059
No abstract available.
7.
Karpathy R, Firth G, Tannock G
Aust Vet J
. 2004 Apr;
81(4):222-5.
PMID: 15080446
Objective: To demonstrate the safety and efficacy of the Marek's Disease Virus-1 vaccine (strain BH 16) from field studies in comparison with the CVI 988 Rispens vaccine currently available in...
8.
Wareing M, Tannock G
Vaccine
. 2003 Jun;
21(23):3097-100.
PMID: 12804835
Serum antibody and antibody secretory cell (ASC) responses to the cold-adapted (CA) live attenuated influenza A donor strain A/Leningrad/134/17/57 in BALB/c mice were determined in the lungs and mediastinal lymph...
9.
Marsh G, Watson J, White W, Tannock G
J Virol Methods
. 2002 Nov;
107(1):63-9.
PMID: 12445939
The influenza A components of live attenuated vaccines used in Russia have been prepared as reassortants of the cold-adapted (ca) H2N2 viruses, A/Leningrad/134/17/57-ca (Len/17) and A/Leningrad/134/47/57-ca (Len/47), and virulent epidemic...
10.
Karpathy R, Firth G, Tannock G
Aust Vet J
. 2002 Aug;
80(1-2):61-6.
PMID: 12180882
Objective: To develop a serotype 1 Marek's disease (MD) vaccine from a very virulent MDV (vvMDV) pathotype and demonstrate safety and efficacy against early challenge with very virulent field strains...